SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-280380
Filing Date
2019-10-31
Accepted
2019-10-31 15:29:30
Documents
95
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d788115d10q.htm   iXBRL 10-Q 2660805
2 EX-31.1 d788115dex311.htm EX-31.1 10725
3 EX-31.2 d788115dex312.htm EX-31.2 10711
4 EX-32.1 d788115dex321.htm EX-32.1 7038
  Complete submission text file 0001193125-19-280380.txt   10902613

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgen-20190930.xsd EX-101.SCH 61513
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20190930_cal.xml EX-101.CAL 63947
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20190930_def.xml EX-101.DEF 561392
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20190930_lab.xml EX-101.LAB 573940
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20190930_pre.xml EX-101.PRE 600935
89 EXTRACTED XBRL INSTANCE DOCUMENT d788115d10q_htm.xml XML 2059057
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 191183473
SIC: 2836 Biological Products, (No Diagnostic Substances)